Fatigue News and Research

RSS

New oral medication shows promise in treating fibromyalgia

A new oral medication known as IMC-1, developed by Innovative Med Concepts, proved highly effective at reducing pain and other symptoms of fibromyalgia (FM) in patients in a recent clinical trial.

18 Nov 2014

Vital exhaustion may increase risk of first-time cardiovascular disease by 36%

Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman's risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association's Scientific Sessions 2014 in Chicago, IL.

17 Nov 2014

Two hospital staff shortlisted as finalists in NHS Leadership Recognition Awards

A CONSULTANT nurse leading the way in cancer care and a manager inspiring a generation of NHS professionals to improve the quality, safety and value of care they provide are to be recognised at a regional award scheme celebrating great leaders in the NHS.

17 Nov 2014

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

17 Nov 2014

New wearable technology could send personalized health alerts to troops, civilians

Wearable devices can count the steps you take and the calories you burn. But can they help soldiers in the field? Or prevent someone from having a heart attack?

13 Nov 2014

Toxicity profiles for everolimus, temsirolimus differ in advanced RCC

Non-infectious pneumonitis and stomatitis occur more frequently in patients with advanced renal cell carcinoma treated with everolimus than temsirolimus, whereas temsirolimus is associated with a higher incidence of fatigue, rash and asthenia, a retrospective study reports.

13 Nov 2014

New NIH-funded study aims to find novel way to treat iron deficiency anemia in children

Penn State College of Medicine and University of Wisconsin have been awarded a five-year, $2.5 million grant from the National Institutes of Health to fund the study of a novel way to treat iron deficiency anemia in children. Iron deficiency is the most common nutritional deficiency and the leading cause of anemia in the United States.

13 Nov 2014

Skin-to-skin contact supports breastfeeding, bonding and better health outcomes

Research during the past 30 years has found many benefits of skin-to-skin contact between mothers and newborns immediately after birth, particularly with aiding breastfeeding. However, in some hospitals, skin-to-skin contact following cesarean birth is not implemented, due to practices around the surgery. A recent Quality Improvement (QI) project demonstrated that women's birth experiences were improved by implementing skin-to-skin contact after cesarean surgery.

12 Nov 2014

New research shows hospital workers wash hands less often as workday progresses

Hospital workers who deal directly with patients wash their hands less frequently as their workday progresses, probably because the demands of the job deplete the mental reserves they need to follow rules, according to new research published by the American Psychological Association.

11 Nov 2014

New drug combination shows promise as effective, safe treatment for rheumatoid arthritis

A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. Doctoral researcher Diederik De Cock (KU Leuven) describes the strategy in a new study published in Annals of Rheumatic Diseases.

11 Nov 2014

National Psoriasis Foundation to hold free psoriatic arthritis program in Dallas-Fort Worth area

If you're one of the roughly 48,000 Dallas-Fort Worth area residents struggling with pain from psoriatic arthritis (PsA)—an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons—learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at the Dallas Marriott Las Colinas on December 6.

10 Nov 2014

Researchers develop standardized, team-based approach to reduce alarm fatigue in hospitals

The sound of monitor alarms in hospitals can save patients' lives, but the frequency with which the monitors go off can also lead to "alarm fatigue," in which caregivers become desensitized to the ubiquitous beeping.

10 Nov 2014

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

7 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Researchers develop new test to identify drugs that could work against Lyme disease

Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a test they say will allow them to test thousands of FDA-approved drugs to see if they will work against the bacteria that causes tick-borne Lyme disease.

4 Nov 2014

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.

4 Nov 2014

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.

4 Nov 2014

$Adults with eczema at greater risk of accidental bone fractures, other injuries$

Adults with eczema at greater risk of accidental bone fractures, other injuries

Intense itching and dry, irritable skin aren't the only problems adults with eczema face. They are at greater risk of accidental bone fractures and other injuries, a new Northwestern Medicine® study has found.

31 Oct 2014

Pre-treatment pain intensity predicts survival of patients with head and neck cancer

Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society.

28 Oct 2014

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

INTEGRA reports on how respiratory drug discovery and development specialists - Pulmocide Ltd. (London, UK) are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

From INTEGRA Biosciences 28 Oct 2014

Fatigue News and Research

New oral medication shows promise in treating fibromyalgia

Vital exhaustion may increase risk of first-time cardiovascular disease by 36%

Two hospital staff shortlisted as finalists in NHS Leadership Recognition Awards

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

New wearable technology could send personalized health alerts to troops, civilians

Toxicity profiles for everolimus, temsirolimus differ in advanced RCC

New NIH-funded study aims to find novel way to treat iron deficiency anemia in children

Skin-to-skin contact supports breastfeeding, bonding and better health outcomes

New research shows hospital workers wash hands less often as workday progresses

New drug combination shows promise as effective, safe treatment for rheumatoid arthritis

National Psoriasis Foundation to hold free psoriatic arthritis program in Dallas-Fort Worth area

Researchers develop standardized, team-based approach to reduce alarm fatigue in hospitals

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Researchers develop new test to identify drugs that could work against Lyme disease

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Adults with eczema at greater risk of accidental bone fractures, other injuries

Pre-treatment pain intensity predicts survival of patients with head and neck cancer

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News